- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Ali Behbahani
- Location
- Menlo Park, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Ali Behbahani.
Follow Filing Activity
Follow Ali Behbahani and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Ali Behbahani
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. | Common Stock, $0.00001 par value per share | 22% | 7,393,823 | Ali Behbahani | 09 Feb 2026 | ||||
| KRRO | Korro Bio, Inc. | Common Stock, par value $0.001 per share | 9.9% | $17,130,522 | 1,456,677 | Ali Behbahani | 10 Mar 2026 | ||
| GLUE | Monte Rosa Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 9.7% | $143,153,471 | 7,797,030 | Ali Behbahani | 17 Mar 2026 |
Schedules 13D/G Reported by Ali Behbahani:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.